Technology Commercialization Office

Showing 3 result(s) for "Drug Screening & Discovery"



Novel method for the electrochemical reduction of apertures to micron and submicron dimensions to construct metallic meshes with ordered arrays of micro- and nano-channels to provide enhanced spectroscopic detection.

Utilizes a fluorescent protein gene sequence to visually distinguish in 3D the effects of chemicals on a developmental protein.

A high-throughput cell-based embryotoxicity screening model for drug discovery.